These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30596704)

  • 1. Trends in South Korean antimicrobial use and association with changes in Escherichia coli resistance rates: 12-year ecological study using a nationwide surveillance and antimicrobial prescription database.
    Kim YA; Park YS; Youk T; Lee H; Lee K
    PLoS One; 2018; 13(12):e0209580. PubMed ID: 30596704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroquinolone-resistant gram-negative bacilli: a KONSAR study in 2002.
    Lee K; Kim YA; Park YJ; Lee HS; Kim MY; Kim EC; Yong D; Chong Y;
    Yonsei Med J; 2004 Aug; 45(4):598-608. PubMed ID: 15344199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department.
    Park KH; Oh WS; Kim ES; Park SW; Hur JA; Kim YK; Moon C; Lee JH; Lee CS; Kim BN
    Int J Infect Dis; 2014 Jun; 23():8-13. PubMed ID: 24657271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology.
    Zemkova M; Kotlarova J; Merka V; Cermak P; Vlcek J; Jebavy L
    New Microbiol; 2007 Oct; 30(4):423-30. PubMed ID: 18080678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals.
    MacDougall C; Powell JP; Johnson CK; Edmond MB; Polk RE
    Clin Infect Dis; 2005 Aug; 41(4):435-40. PubMed ID: 16028149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact.
    Shin J; Kim J; Wie SH; Cho YK; Lim SK; Shin SY; Yeom JS; Lee JS; Kweon KT; Lee H; Cheong HJ; Park SH; Park DW; Ryu SY; Chung MH; Yoo S; Pai H
    Microb Drug Resist; 2012 Apr; 18(2):169-75. PubMed ID: 22400491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location.
    Boyd LB; Atmar RL; Randall GL; Hamill RJ; Steffen D; Zechiedrich L
    BMC Infect Dis; 2008 Jan; 8():4. PubMed ID: 18197977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between antimicrobial consumption and resistance in Escherichia coli.
    Bergman M; Nyberg ST; Huovinen P; Paakkari P; Hakanen AJ;
    Antimicrob Agents Chemother; 2009 Mar; 53(3):912-7. PubMed ID: 19104012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolone consumption and Escherichia coli resistance in Japan: an ecological study.
    Terahara F; Nishiura H
    BMC Public Health; 2019 Apr; 19(1):426. PubMed ID: 31014305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between antimicrobial consumption and resistance rate of Escherichia coli in hospital settings.
    Abdullah S; Rahman SU; Muhammad F; Mohsin M
    J Appl Microbiol; 2023 Jan; 134(1):. PubMed ID: 36626753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antimicrobial consumption on Escherichia coli resistance: assessment and forecasting using Dynamic Regression models in a French university hospital (2014-2019).
    Laffont-Lozes P; Salipante F; Leguelinel-Blache G; Dunyach-Remy C; Lavigne JP; Sotto A; Larcher R
    Int J Antimicrob Agents; 2023 May; 61(5):106768. PubMed ID: 36878409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between antimicrobial resistance in Escherichia coli isolates from food animals and blood stream isolates from humans in Europe: an ecological study.
    Vieira AR; Collignon P; Aarestrup FM; McEwen SA; Hendriksen RS; Hald T; Wegener HC
    Foodborne Pathog Dis; 2011 Dec; 8(12):1295-301. PubMed ID: 21883007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of fluoroquinolone resistance in Escherichia coli. A five-year trend in Australia measured through the use of TSN Database Australia.
    Turnidge J; McCarthy LR; Master RN; Kepner DE
    Commun Dis Intell Q Rep; 2003; 27 Suppl():S89-91. PubMed ID: 12807281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess body weight and age associated with the carriage of fluoroquinolone and third-generation cephalosporin resistance genes in commensal Escherichia coli from a cohort of urban Vietnamese children.
    Thi Quynh Nhi L; Thanh Tuyen H; Duc Trung P; Do Hoang Nhu T; Duy PT; Hao CT; Thi Thanh Nhan N; Vi LL; Thi Diem Tuyet H; Thi Thuy Tien T; Van Vinh Chau N; Khanh Lam P; Thwaites G; Baker S
    J Med Microbiol; 2018 Oct; 67(10):1457-1466. PubMed ID: 30113307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar cefoxitin-resistance plasmids circulating in Escherichia coli from human and animal sources.
    Mulvey MR; Susky E; McCracken M; Morck DW; Read RR
    Vet Microbiol; 2009 Mar; 134(3-4):279-87. PubMed ID: 18824313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.
    Urbánek K; Kolár M; Strojil J; Koukalová D; Cekanová L; Hejnar P
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):741-5. PubMed ID: 15880441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital.
    Gallini A; Degris E; Desplas M; Bourrel R; Archambaud M; Montastruc JL; Lapeyre-Mestre M; Sommet A
    J Antimicrob Chemother; 2010 Dec; 65(12):2650-7. PubMed ID: 20876240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between antimicrobial resistance in Escherichia coli infections in hospitalized patients and rates of inpatient prescriptions for selected antimicrobial agents, Department of Defense hospitals, 2010-2014.
    Spencer JR; Milburn EK; Chukwuma U
    MSMR; 2016 Mar; 23(3):6-10. PubMed ID: 27030926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.